HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyperbaric oxygen therapy improves early posttransplant islet function.

AbstractOBJECTIVE:
This study investigates the therapeutic potential of hyperbaric oxygen therapy (HBO) in reducing hypoxia and improving engraftment of intraportal islet transplants by promoting angiogenesis.
METHODS:
Diabetic BALB/c mice were transplanted with 500 syngeneic islets intraportally and received six consecutive twice-daily HBO treatments (n = 9; 100% oxygen for 1 h at 2.5 atmospheres absolute) after transplantation. Dynamic contrast-enhanced magnetic resonance imaging (DCE MRI) was used to assess new vessel formation at postoperative days (POD) 3, 7, and 14. Liver tissue was recovered at the same time points for correlative histology, including: hematoxylin and eosin, hypoxia-inducible factor (HIF1α), Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end labeling (TUNEL), vascular endothelial growth factor (VEGF), and von Willebrand Factor immunohistochemistry.
RESULTS:
HBO therapy significantly reduced HIF-1α, TUNEL and VEGF expression in islets at POD 7. In the non-HBO transplants, liver enhancement on DCE MRI peaked at POD 7 consistent with less mature vasculature but this enhancement was suppressed at POD 7 in the HBO-treated group. The number of new peri-islet vessels at POD 7 was not significantly different between HBO and control groups.
CONCLUSION:
These results are consistent with a hyperbaric oxygen-mediated decrease in hypoxia that appeared to enhance vessel maturation in the critical days following intraportal islet transplantation.
AuthorsNaoaki Sakata, Nathaniel K Chan, Robert P Ostrowski, John Chrisler, Pete Hayes, Sonny Kim, Andre Obenaus, John H Zhang, Eba Hathout
JournalPediatric diabetes (Pediatr Diabetes) Vol. 11 Issue 7 Pg. 471-8 (Nov 2010) ISSN: 1399-5448 [Electronic] Denmark
PMID20144181 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2010 John Wiley & Sons A/S.
Chemical References
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Vascular Endothelial Growth Factor A
Topics
  • Animals
  • Diabetes Mellitus, Experimental (therapy)
  • Hyperbaric Oxygenation
  • Hypoxia-Inducible Factor 1, alpha Subunit (metabolism)
  • In Situ Nick-End Labeling
  • Islets of Langerhans (blood supply, physiology)
  • Islets of Langerhans Transplantation (methods)
  • Magnetic Resonance Imaging
  • Mice
  • Mice, Inbred BALB C
  • Neovascularization, Physiologic (drug effects)
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: